Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 17,249 | 19,377 | 21,202 | 16,756 | 18,632 |
| Other current assets | 216 | 303 | 599 | 169 | 379 |
| TOTAL | $17,465 | $19,680 | $21,801 | $16,925 | $19,011 |
| Non-Current Assets | |||||
| PPE Net | 26 | 29 | 26 | 29 | 27 |
| Other Non-Current Assets | 548 | 831 | 828 | 130 | 100 |
| TOTAL | $574 | $860 | $854 | $159 | $127 |
| Total Assets | $18,039 | $20,540 | $22,655 | $17,084 | $19,138 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 365 | 725 | 552 | 597 | 447 |
| Accrued Expenses | 473 | 492 | 568 | 905 | 322 |
| TOTAL | $838 | $1,217 | $1,120 | $1,502 | $769 |
| Non-Current Liabilities | |||||
| TOTAL | $3 | $2 | $1 | $1 | $N/A |
| Total Liabilities | $841 | $1,219 | $1,121 | $1,503 | $769 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14 | 14 | 14 | 14 | 10 |
| Common Shares | 21 | 21 | 21 | 16 | 13 |
| Retained earnings | -82,011 | -79,727 | -77,322 | -74,933 | -71,987 |
| TOTAL | $17,198 | $19,321 | $21,534 | $15,581 | $18,369 |
| Total Liabilities And Equity | $18,039 | $20,540 | $22,655 | $17,084 | $19,138 |